1. Home
  2. ANIX vs PROP Comparison

ANIX vs PROP Comparison

Compare ANIX & PROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.72

Market Cap

88.8M

Sector

Health Care

ML Signal

HOLD

Logo Prairie Operating Co.

PROP

Prairie Operating Co.

HOLD

Current Price

$0.93

Market Cap

105.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
PROP
Founded
1982
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
88.8M
105.6M
IPO Year
2013
2008

Fundamental Metrics

Financial Performance
Metric
ANIX
PROP
Price
$2.72
$0.93
Analyst Decision
Strong Buy
Buy
Analyst Count
3
5
Target Price
$8.67
$6.75
AVG Volume (30 Days)
94.4K
3.2M
Earning Date
05-27-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
12.82
49.06
EPS
N/A
N/A
Revenue
$210,000.00
$7,939,000.00
Revenue This Year
N/A
$81.83
Revenue Next Year
N/A
$18.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
413.59
52 Week Low
$2.44
$0.77
52 Week High
$5.46
$4.33

Technical Indicators

Market Signals
Indicator
ANIX
PROP
Relative Strength Index (RSI) 42.94 42.56
Support Level $2.65 $0.77
Resistance Level $3.12 $1.93
Average True Range (ATR) 0.12 0.09
MACD -0.02 0.02
Stochastic Oscillator 28.21 58.15

Price Performance

Historical Comparison
ANIX
PROP

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About PROP Prairie Operating Co.

Prairie Operating Co is a Houston-based independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States. The Company's assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a focus on the Niobrara and Codell formations. The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.

Share on Social Networks: